Humana Return on Tangible Equity 2010-2024 | HUM
Current and historical return on tangible equity values for Humana (HUM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Humana Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-09-30 |
$1.36B |
$8.03B |
19.02% |
| 2024-06-30 |
$1.71B |
$7.16B |
24.43% |
| 2024-03-31 |
$1.99B |
$6.62B |
28.23% |
| 2023-12-31 |
$2.49B |
$6.77B |
34.45% |
| 2023-09-30 |
$3.02B |
$7.46B |
42.53% |
| 2023-06-30 |
$3.38B |
$7.35B |
48.06% |
| 2023-03-31 |
$3.12B |
$7.31B |
45.54% |
| 2022-12-31 |
$2.81B |
$6.23B |
46.28% |
| 2022-09-30 |
$2.81B |
$7.22B |
48.75% |
| 2022-06-30 |
$3.14B |
$6.60B |
59.05% |
| 2022-03-31 |
$3.04B |
$4.20B |
49.31% |
| 2021-12-31 |
$2.93B |
$5.01B |
39.10% |
| 2021-09-30 |
$2.67B |
$5.48B |
31.20% |
| 2021-06-30 |
$2.48B |
$9.93B |
24.74% |
| 2021-03-31 |
$3.72B |
$9.59B |
37.07% |
| 2020-12-31 |
$3.37B |
$9.28B |
34.99% |
| 2020-09-30 |
$4.15B |
$11.33B |
44.51% |
| 2020-06-30 |
$3.50B |
$9.97B |
41.60% |
| 2020-03-31 |
$2.61B |
$7.91B |
33.04% |
| 2019-12-31 |
$2.71B |
$8.11B |
35.29% |
| 2019-09-30 |
$2.55B |
$7.68B |
35.37% |
| 2019-06-30 |
$2.51B |
$7.95B |
35.97% |
| 2019-03-31 |
$1.76B |
$6.94B |
26.82% |
| 2018-12-31 |
$1.68B |
$6.26B |
26.30% |
| 2018-09-30 |
$1.51B |
$6.70B |
23.35% |
| 2018-06-30 |
$1.37B |
$6.32B |
20.16% |
| 2018-03-31 |
$1.82B |
$6.32B |
25.61% |
| 2017-12-31 |
$2.45B |
$6.56B |
33.63% |
| 2017-09-30 |
$1.86B |
$7.93B |
24.86% |
| 2017-06-30 |
$1.81B |
$7.67B |
24.14% |
| 2017-03-31 |
$1.48B |
$6.96B |
19.67% |
| 2016-12-31 |
$0.61B |
$7.41B |
8.11% |
| 2016-09-30 |
$1.12B |
$8.01B |
14.90% |
| 2016-06-30 |
$0.98B |
$7.61B |
13.50% |
| 2016-03-31 |
$1.10B |
$7.26B |
15.58% |
| 2015-12-31 |
$1.28B |
$7.08B |
18.36% |
| 2015-09-30 |
$1.32B |
$7.09B |
19.46% |
| 2015-06-30 |
$1.30B |
$6.82B |
19.58% |
| 2015-03-31 |
$1.21B |
$6.81B |
18.63% |
| 2014-12-31 |
$1.15B |
$6.42B |
18.22% |
| 2014-09-30 |
$0.97B |
$6.43B |
15.97% |
| 2014-06-30 |
$1.05B |
$6.30B |
17.64% |
| 2014-03-31 |
$1.13B |
$6.03B |
19.42% |
| 2013-12-31 |
$1.23B |
$5.58B |
21.70% |
| 2013-09-30 |
$1.45B |
$5.89B |
26.04% |
| 2013-06-30 |
$1.51B |
$5.70B |
27.28% |
| 2013-03-31 |
$1.45B |
$5.52B |
26.16% |
| 2012-12-31 |
$1.22B |
$5.21B |
22.17% |
| 2012-09-30 |
$1.23B |
$5.73B |
22.18% |
| 2012-06-30 |
$1.25B |
$5.66B |
22.99% |
| 2012-03-31 |
$1.35B |
$5.45B |
25.68% |
| 2011-12-31 |
$1.42B |
$5.32B |
28.01% |
| 2011-09-30 |
$1.33B |
$5.28B |
27.51% |
| 2011-06-30 |
$1.28B |
$5.01B |
26.90% |
| 2011-03-31 |
$1.16B |
$4.65B |
25.06% |
| 2010-12-31 |
$1.10B |
$4.36B |
24.59% |
| 2010-09-30 |
$1.24B |
$4.94B |
28.74% |
| 2010-06-30 |
$1.15B |
$4.48B |
28.96% |
| 2010-03-31 |
$1.09B |
$4.09B |
30.19% |
| 2009-12-31 |
$1.04B |
$3.78B |
31.83% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Health Maintenance Organizations |
$28.391B |
$106.374B |
|
Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana's medical and specialty insurance products allow members to access health care services primarily through its networks of health care providers. The company manages its business through the following segments: The Retail segment consists of Medicare benefits, which are marketed on a retail basis to individuals. The Group and Specialty segment comprises employer group commercial fully-insured medical and specialty health insurance benefits. The Healthcare Services - The segment consists of services offered to the company's health plan members as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs.
|
